TrialArthritis and rheumatism2011

Imatinib in active diffuse cutaneous systemic sclerosis: Results of a six-month, randomized, double-blind, placebo-controlled, proof-of-concept pilot study at a single center.

Janet Pope et al.PubMed ↗Publisher ↗

No numbers read from the abstract.